Pressure on duloxetine as generic makers flag shortages

There's heavy demand, but Eli Lilly says they can meet it

There are concerns of a looming shortage of duloxetine after generic versions were pulled from the market last year.


Two generic versions of the antidepressant were withdrawn in November, but now three other generic manufacturers have formally alerted the TGA of shortages running at least until the end of the month.

A number of pharmacists and patients have raised concerns through social media about shortages of the branded drug Cymbalta.

Manufacturer Eli Lilly told Australian Doctor: “[We are] experiencing increased